Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.32 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.32 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.32 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.32 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12323375 | 1.00 | CYP2C19 (0.40) | CYP2C19CYP1A2EPHX1PAOXMAPT | |
| SCHEMBL23739843 | 1.00 | CYP2C19 (0.40) | CYP2C19CYP1A2EPHX1PAOXMAPT | |
| SCHEMBL14548641 | 0.91 | CYP2C19 (0.36) | CYP2C19CYP1A2EPHX1PAOXMAPT | |
| SCHEMBL12319688 | 0.90 | CYP2C19 (0.48) | CYP2C19CYP1A2MAPTALDH1A1TSHR | |
| SCHEMBL11044686 | 0.90 | CYP2C19 (0.48) | CYP2C19CYP1A2MAPTALDH1A1TSHR | |
| SCHEMBL8222606 | 0.90 | — | — | |
| SCHEMBL11293486 | 0.90 | EPHX1 (0.46) | EPHX1PAOXHRH4HRH3SIGMAR1 | |
| SCHEMBL22458762 | 0.87 | EPHX1 (0.50) | EPHX1PAOXMAPTHRH4HRH3 | |
| SCHEMBL18458888 | 0.87 | EPHX1 (0.50) | EPHX1PAOXMAPTHRH4HRH3 | |
| SCHEMBL21880702 | 0.87 | EPHX1 (0.50) | EPHX1PAOXMAPTHRH4HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024064769-A1 | INDUCTION OF STEM-LIKE ACTIVATED T CELLS | PHIO PHARMACEUTICALS CORP. (US) | 2024-03-28 | — | — | WO | disclosed |
| WO-2023130021-A1 | CHEMICALLY MODIFIED OLIGONUCLEOTIDES WITH IMPROVED DELIVERY PROPERTIES | PHIO PHARMACEUTICALS CORP. (US) | 2023-07-06 | — | — | WO | disclosed |
| WO-2023015265-A2 | CHEMICALLY MODIFIED OLIGONUCLEOTIDES | PHIO PHARMACEUTICALS CORP. (US) | 2023-02-09 | — | — | WO | disclosed |
| WO-2023015264-A1 | IMMUNOTHERAPY OF CANCER UTILIZING NATURAL KILLER CELLS TREATED WITH CHEMICALLY MODIFIED OLIGONUCLEOTIDES | PHIO PHARMACEUTICALS CORP. (US) | 2023-02-09 | — | — | WO | disclosed |
| EP-3188799-B1 | METHODS FOR TREATING AGING AND SKIN DISORDERS USING NUCLEIC ACIDS TARGETING TYR OR MMP1 | PHIO PHARM CORP (US) | 2022-07-06 | — | — | EP | disclosed |
| EP-3560503-B1 | RNA INTERFERENCE IN DERMAL AND FIBROTIC INDICATIONS | PHIO PHARM CORP (US) | 2021-11-17 | — | — | EP | disclosed |
| EP-3578183-B1 | RNA INTERFERENCE IN OCULAR INDICATIONS | PHIO PHARM CORP (US) | 2021-09-08 | — | — | EP | disclosed |
| EP-3862005-A1 | NUCLEIC ACID MOLECULES TARGETING SUPEROXIDE DISMUTASE 1 (SOD1) | Phio Pharmaceuticals Corp. (US) | 2021-08-11 | — | — | EP | disclosed |
| WO-2021138537-A1 | CHEMICALLY MODIFIED OLIGONUCLEOTIDES WITH IMPROVED SYSTEMIC DELIVERY | PHIO PHARMACEUTICALS CORP. (US) | 2021-07-08 | — | — | WO | disclosed |
| EP-3319614-B1 | NUCLEIC ACID MOLECULES TARGETING SUPEROXIDE DISMUTASE 1 (SOD1) | PHIO PHARM CORP (US) | 2020-12-23 | — | — | EP | disclosed |
| EP-3137119-B1 | METHODS FOR TREATING CANCER USING A NUCLEIC ACID TARGETING MDM2 | PHIO PHARM CORP (US) | 2020-07-01 | — | — | EP | disclosed |
| WO-2019032619-A9 | CHEMICALLY MODIFIED OLIGONUCLEOTIDES | PHIO PHARMACEUTICALS CORP. (US) | 2020-02-13 | — | — | WO | disclosed |
| EP-2550001-B1 | RNA INTERFERENCE IN OCULAR INDICATIONS | PHIO PHARM CORP (US) | 2019-05-22 | — | — | EP | disclosed |
| EP-2550002-B1 | RNA INTERFERENCE IN DERMAL AND FIBROTIC INDICATIONS | PHIO PHARM CORP (US) | 2019-05-08 | — | — | EP | disclosed |
| WO-2019032619-A1 | CHEMICALLY MODIFIED OLIGONUCLEOTIDES | PHIO PHARMACEUTICALS CORP. (US) | 2019-02-14 | — | — | WO | disclosed |